Aurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally. The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key therapeutic areas, including central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and provides project-based chemistry contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
| 1220 | |
| 1254 | |
| - | |
| 1254 | |
| 1216 | |
| 957.1108-1592 | |
| 708 578 M | |
| 19.9184 | |
| 581 M | |
| 302 950 M | |
| 14 | |
| 0.0036 | |
| 0.593 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
BENGALURU (Reuters) - India's federal financial crime agency has arrested P. Sarath Chandra Reddy, a director of Aurobindo Pharma Ltd, the drugmaker said in an exchange filing on Thursday. Several me...
The FDA has repeatedly cited India's Aurobindo for unsafe manufacturing practices, but still lets it dominate the U.S. market for generic drugs.
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
